About
Iterative Scopes GI AI, developed by Iterative Health, is a specialized clinical research platform that combines a performance-driven global site network with AI-powered tools to transform how GI and Hepatology clinical trials are conducted. The platform embeds research directly into community-based care settings, partnering with leading provider networks such as GI Alliance and One GI to bring trials closer to patients who need them most. Designed for both sponsors/CROs and clinical research sites (providers), the platform addresses core inefficiencies in trial execution—slow site activation, low patient enrollment, and high operational burden—through intelligent automation and targeted AI tools. Sites gain access to top-tier studies, operational support, and AI-driven patient identification workflows that supercharge enrollment rates. Sponsors benefit from confident site selection, unparalleled activation speed, and industry-leading enrollment outcomes. With a global network of research sites, a multi-million patient reach, and demonstrated improvements in enrollment and activation timelines, Iterative Scopes GI AI is purpose-built for the unique demands of GI and hepatology research. It serves investigators, sponsors, CROs, and clinical operations teams looking to accelerate life-changing therapies to market while expanding equitable access to clinical trials across community practices.
Key Features
- AI-Powered Patient Enrollment: Leverages artificial intelligence to identify and engage eligible patients for GI and Hepatology clinical trials, significantly increasing enrollment rates.
- Global Community-Embedded Site Network: Partners with GI Alliance and One GI to place research sites inside community care practices, expanding patient reach and accelerating site activation.
- Sponsor & CRO Partnership Tools: Provides sponsors and CROs with data-driven site selection, operational transparency, and performance metrics to ensure high-quality trial execution.
- Operational Excellence Support: Reduces administrative burden on research sites through proactive chart reviews, targeted patient outreach, and streamlined trial management workflows.
- Therapeutic Specialization in GI & Hepatology: Deep domain expertise in gastroenterology and hepatology ensures trial designs, site selection, and patient populations are optimally aligned.
Use Cases
- A pharmaceutical sponsor accelerating a Phase 2 IBD (inflammatory bowel disease) trial by leveraging Iterative Health's pre-qualified GI site network for faster activation and enrollment.
- A gastroenterology practice joining the site network to access top-tier clinical trials, generate research revenue, and offer patients access to novel therapies.
- A CRO using the platform's AI-powered patient identification tools to meet aggressive enrollment timelines for a hepatology drug trial.
- A biotech company partnering with Iterative Health to run a complex Phase 1b GI trial with operational support, proactive chart reviews, and high patient retention.
- A community GI clinic expanding its research capabilities without building an internal team, using Iterative Health's infrastructure and AI tools to run trials efficiently.
Pros
- Specialized GI & Hepatology Focus: Deep therapeutic expertise ensures faster, higher-quality trial execution compared to generalist CRO networks.
- Community-Based Access at Scale: Embedding trials in everyday care settings dramatically expands patient reach and reduces barriers to participation.
- Demonstrated Enrollment & Activation Speed: Platform delivers measurably faster site activation and patient enrollment rates, reducing overall time-to-market for novel therapies.
Cons
- Narrow Therapeutic Scope: The platform is focused exclusively on GI and Hepatology, limiting its applicability for sponsors working in other therapeutic areas.
- Enterprise-Only Pricing: Designed for large sponsors, CROs, and established research sites—not accessible for small independent researchers or academic institutions with limited budgets.
Frequently Asked Questions
What therapeutic areas does Iterative Scopes GI AI specialize in?
The platform specializes exclusively in Gastroenterology (GI) and Hepatology clinical research, providing deep domain expertise and a curated network of sites focused on these conditions.
How does the AI component help with patient enrollment?
The AI tools analyze patient data within connected community practices to identify eligible trial participants, automate outreach, and streamline the screening process, resulting in significantly higher enrollment rates.
Who are the primary users of this platform?
The platform serves two primary audiences: clinical research sites and providers looking to grow their research capabilities, and pharmaceutical sponsors and CROs seeking high-performing GI/Hepatology trial sites.
What makes Iterative Health's site network different from other CROs?
Iterative Health embeds research directly into community-based care settings through strategic partnerships with GI Alliance and One GI, giving access to a large, diverse patient population that traditional academic research sites often miss.
Is there a free trial or demo available?
As an enterprise clinical research platform, Iterative Health typically engages through direct partnership discussions. Interested sponsors or providers should contact the team through their website to explore partnership options.
